{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:05:14Z","timestamp":1756811114110,"version":"3.44.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic subdural hematoma (CSDH) presents a growing challenge in neurosurgical care due to its increasing incidence, recurrence rates, and aging-related risk factors. Treatment approaches vary widely, particularly in Southeast Asia, where limited data exists regarding standardized management. This study aims to evaluate current clinical practices and emerging treatment trends for CSDH among Thai neurosurgeons.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A nationwide cross-sectional survey was conducted in January 2025 among practicing neurosurgeons across Thailand. The 29-item web-based questionnaire covered demographics, surgical techniques, adjunct therapies, and postoperative care. Descriptive statistics were used to summarize responses. Results were synthesized and compared with previously published nationwide surveys to identify practice trends and deviations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 53 responses were received (76% response rate). Most respondents practiced in public hospitals (71.7%) and managed 10\u201330 CSDH cases annually (56.6%). The preferred surgical method was two burr-hole craniostomy (73.6%), with 96.2% of surgeons using intraoperative irrigation, predominantly with room-temperature normal saline. Drain placement was nearly universal (96.2%), with 72.5% opting for subdural drains. Postoperative care varied, with 30.2% prescribing 48-h bed rest and 66% not performing routine postoperative CT scans. Corticosteroids were used by 37.7%, mostly in conservative cases, while 40% prescribed statins, and 39.6% utilized tranexamic acid. Adjunctive middle meningeal artery (MMA) embolization was employed by 45.3% of respondents. Decisions to resume antiplatelet or anticoagulant therapy were guided by postoperative imaging in over half of the cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This survey highlights substantial heterogeneity in the management of chronic subdural hematoma (CSDH) across Thailand. While burr-hole craniostomy with irrigation and drainage remains the standard surgical approach, notable variations exist in medical therapy and postoperative care. The widespread use of middle meningeal artery (MMA) embolization and other adjunctive therapies reflects evolving treatment trends. These findings emphasize the need for national, evidence-based guidelines to standardize care, reduce variability, and improve patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1636167","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:11:03Z","timestamp":1756699863000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic subdural hematoma management in Thailand: a nationwide survey of clinical practice and trends"],"prefix":"10.3389","volume":"16","author":[{"given":"Todsapon","family":"Praphanuwat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanon","family":"Srihagulang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriengsak","family":"Limpastan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thunya","family":"Norasethada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanat","family":"Vaniyapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanarak","family":"Watcharasaksilp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chumpon","family":"Jetjumnong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phonphimon","family":"Ruankham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirapong","family":"Vongsfak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jocn.2018.01.050","article-title":"Evidence based diagnosis and management of chronic subdural hematoma: a review of the literature","volume":"50","author":"Mehta","year":"2018","journal-title":"J Clin Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.wneu.2020.06.140","article-title":"Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome","volume":"141","author":"Feghali","year":"2020","journal-title":"World Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.nec.2016.11.002","article-title":"Chronic subdural hematoma: epidemiology and natural history","volume":"28","author":"Yang","year":"2017","journal-title":"Neurosurgery Clinics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2176\/nmc.ra.2016-0337","article-title":"Chronic subdural hematoma in elderly patients: is this disease benign?","volume":"57","author":"Uno","year":"2017","journal-title":"Neurol Med Chir"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1056\/NEJMoa2020473","article-title":"Trial of dexamethasone for chronic subdural hematoma","volume":"383","author":"Hutchinson","year":"2020","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e829","DOI":"10.1016\/j.wneu.2023.12.054","article-title":"Adjuvant tranexamic acid for reducing postoperative recurrence of chronic subdural hematoma in the elderly: a systematic review and meta-analysis","volume":"182","author":"Albalkhi","year":"2024","journal-title":"World Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e35379","DOI":"10.1097\/MD.0000000000035379","article-title":"Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma","volume":"102","author":"Xu","year":"2023","journal-title":"Medicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/neurintsurg-2021-017352","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis","volume":"13","author":"Ironside","year":"2021","journal-title":"J Neurointerventional Surgery"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jnnp.74.7.937","article-title":"Outcome of contemporary surgery for chronic subdural haematoma: evidence based review","volume":"74","author":"Weigel","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.wneu.2017.04.134","article-title":"Drain insertion in chronic subdural hematoma: an international survey of practice","volume":"104","author":"Soleman","year":"2017","journal-title":"World Neurosurg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/2152-7806.110657","article-title":"Chronic subdural hematoma: a survey of neurosurgeons\u2019 practices in Nigeria","volume":"4","author":"Rabiu","year":"2013","journal-title":"Surg Neurol Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/02688690802195381","article-title":"The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland","volume":"22","author":"Santarius","year":"2008","journal-title":"Br J Neurosurg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1227\/neu.0000000000002144","article-title":"Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases","volume":"91","author":"Henry","year":"2022","journal-title":"Neurosurgery"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa2216767","article-title":"Dexamethasone versus surgery for chronic subdural hematoma","volume":"388","author":"Miah","year":"2023","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"106548","DOI":"10.1016\/j.clineuro.2021.106548","article-title":"The effect of atorvastatin on recurrence of chronic subdural hematoma after novel YL-1 puncture needle surgery","volume":"202","author":"Wang","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.wneu.2024.05.069","article-title":"Efficacy and safety of atorvastatin for chronic subdural hematoma: an updated systematic review and meta-analysis","volume":"188","author":"de Almeida","year":"2024","journal-title":"World Neurosurg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1359354","DOI":"10.3389\/fneur.2024.1359354","article-title":"Effectiveness of tranexamic acid on chronic subdural hematoma recurrence: a meta-analysis and systematic review","volume":"15","author":"Pan","year":"2024","journal-title":"Front Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e18868","DOI":"10.7759\/cureus.18868","article-title":"Middle meningeal artery embolization and the treatment of a chronic subdural hematoma","volume":"13","author":"D\u00e9sir","year":"2021","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1227\/neu.0000000000002365","article-title":"Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis","volume":"92","author":"Sattari","year":"2023","journal-title":"Neurosurgery"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0000000000003918","article-title":"Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review","volume":"88","author":"Nathan","year":"2017","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.wneu.2017.08.065","article-title":"The management of patients with chronic subdural hematoma treated with low-dose acetylsalicylic acid: an international survey of practice","volume":"107","author":"Soleman","year":"2017","journal-title":"World Neurosurg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1017\/s0317167100004510","article-title":"Management of chronic subdural hematoma: a national survey and literature review","volume":"32","author":"Cenic","year":"2005","journal-title":"Can J Neurol Sci."},{"key":"ref23","first-page":"617","article-title":"The optimal surgical approach for treatment of chronic subdural hematoma: questionnaire assessment of practice in Iran and review of literature","volume":"53","author":"Javadi","year":"2015","journal-title":"Acta Med Iran."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.wneu.2016.09.010","article-title":"Chronic subdural hematoma: a questionnaire survey of management practice in India and review of literature","volume":"96","author":"Avanali","year":"2016","journal-title":"World Neurosurg."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1590\/0004-282X20180082","article-title":"Management of chronic subdural hematoma in Brazil","volume":"76","author":"Teles","year":"2018","journal-title":"Arq Neuropsiquiatr."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e983","DOI":"10.1016\/j.wneu.2018.05.145","article-title":"Treatment standards for chronic subdural hematoma: results from a survey in Austrian, German, and Swiss neurosurgical units","volume":"116","author":"Baschera","year":"2018","journal-title":"World Neurosurg."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e2463","DOI":"10.1002\/brb3.2463","article-title":"National survey on the current practice and attitudes toward the management of chronic subdural hematoma","volume":"12","author":"Holl","year":"2022","journal-title":"Brain Behav."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1636167","DOI":"10.3389\/fneur.2025.1636167","article-title":"Chronic subdural hematoma management in Thailand: a nationwide survey of clinical practice and trends","volume":"16","author":"Praphanuwat","year":"2025","journal-title":"Front Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1636167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:11:04Z","timestamp":1756699864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1636167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":28,"alternative-id":["10.3389\/fneur.2025.1636167"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1636167","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"1636167"}}